SPOTLIGHT -
A case study details the care of a patient who had already lost vision in one eye from a similar issue.
Multiple companies announce data presentations at ARVO 2024
(EyePod) From idea to impact: Navigating ophthalmic innovation
SalioGen Therapeutics taps development candidate for ABCA4-mediated Stargardt disease
Eyepod: Ocugen CEO gives update on OCU400
Ocular Therapeutix announces positive topline Phase 1 data for Axpaxli in diabetic retinopathy
Kiora Pharmaceuticals receives grant to fund novel clinical trial endpoints for inherited retinal diseases